- Round ID
- FR-00223
- Stage
- Series D
- Round name
- Series D
- Amount
- $225M equity (plus up to $300M SoftBank commitment; up to $525M total)
Dated funding evidence
Exscientia
Series D · $225M equity (plus up to $300M SoftBank commitment; up to $525M total) · 2021-04-01
Reported round$225M equity (plus up to $300M SoftBank commitment; up to $525M total)Series D
- Disclosure date
- 2021-04-01
- Reported currency
- USD
- Companies House
- 13483814
- Evidence sources
- 2
Company
ExscientiaCH 134838142021-04-01Series D$225M equity (plus up to $300M SoftBank commitment; up to $525M total)
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- SoftBank Vision Fund 2
- Other investors
- Novo Holdings, BlackRock, Mubadala Investment Company, Farallon Capital, Casdin Capital, GT Healthcare Capital, Marshall Wace, Pivotal bioVenture Partners, Bristol Myers Squibb
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.